Cargando…
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834767/ https://www.ncbi.nlm.nih.gov/pubmed/33423787 http://dx.doi.org/10.1016/j.therap.2020.12.015 |
| _version_ | 1783642357953986560 |
|---|---|
| author | Kow, Chia Siang Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7834767 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78347672021-01-26 A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 Kow, Chia Siang Hasan, Syed Shahzad Therapie Letter to the Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021 2020-12-26 /pmc/articles/PMC7834767/ /pubmed/33423787 http://dx.doi.org/10.1016/j.therap.2020.12.015 Text en © 2020 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Kow, Chia Siang Hasan, Syed Shahzad A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
| title | A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
| title_full | A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
| title_fullStr | A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
| title_full_unstemmed | A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
| title_short | A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19 |
| title_sort | meta-analysis on the preadmission use of dpp-4 inhibitors and risk of a fatal or severe course of illness in patients with covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834767/ https://www.ncbi.nlm.nih.gov/pubmed/33423787 http://dx.doi.org/10.1016/j.therap.2020.12.015 |
| work_keys_str_mv | AT kowchiasiang ametaanalysisonthepreadmissionuseofdpp4inhibitorsandriskofafatalorseverecourseofillnessinpatientswithcovid19 AT hasansyedshahzad ametaanalysisonthepreadmissionuseofdpp4inhibitorsandriskofafatalorseverecourseofillnessinpatientswithcovid19 AT kowchiasiang metaanalysisonthepreadmissionuseofdpp4inhibitorsandriskofafatalorseverecourseofillnessinpatientswithcovid19 AT hasansyedshahzad metaanalysisonthepreadmissionuseofdpp4inhibitorsandriskofafatalorseverecourseofillnessinpatientswithcovid19 |